To investigate the regulation of type II collagen gene expression in c
ells undergoing chondrogenic differentiation, we have employed a 5-kbp
genomic fragment of the human type II collagen gene which contains 1.
8 kbp of upstream sequences, the transcription start site, the first e
xon and 3 kbp of intronic sequences, fused to either lac Z or chloramp
henicol acetyl transferase-reporter gene. Transient expression studies
revealed a parallel increase in transgene activity and endogenous typ
e II collagen mRNA levels during the onset of the cartilage differenti
ation of limb mesenchymal cells in high-density micromass cultures. At
later periods in culture, however, the transgene activity declines, a
lthough steady-state levels of type II collagen mRNA are reported to c
ontinue to increase (Kosher et al.: J. Cell. Biol. 202: 1151-1156, 198
6; Kravis and Upholt. Dev. Biol. 108: 164-172, 1985). In addition, the
activity of the transgene is seven-fold higher at the onset of chondr
ogenic differentiation in micromass cultures than in well differentiat
ed sternal chondrocytes, although similar levels of type II collagen t
ranscripts are found in these cells. Furthermore, deletions of introni
c segments resulted in greater drop in activity of the constructs in d
ifferentiating chondrocytes in micromass cultures than in mature stern
al chondrocytes. The expression of the construct in transgenic mice is
higher at the onset of chondrogenic differentiation and in newly diff
erentiated chondrocytes than in more mature differentiated chondrocyte
s. Based on these observations, it appears that the mechanisms involve
d in the regulation of the type II collagen gene at the onset of chond
rocyte differentiation are different from those resulting in the maint
ainance of its expression in fully differentiated chondrocytes.